SNDL Inc.
$1.44+4.35%(+$0.06)
TickerSpark Score
60/100
80
Valuation
30
Profitability
70
Growth
68
Health
50
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNDL research report →
52-Week Range17% of range
Low $1.15
Current $1.44
High $2.89
Companywww.sndlgroup.com
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments.
- CEO
- Zachary Ryan George
- IPO
- 2019
- Employees
- 2,604
- HQ
- Calgary, AB, CA
Price Chart
+8.27% · this period
Valuation
- Market Cap
- $373.25M
- P/E
- -46.91
- P/S
- 0.55
- P/B
- 0.47
- EV/EBITDA
- 9.03
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 27.18%
- Op Margin
- -0.79%
- Net Margin
- -1.17%
- ROE
- -1.00%
- ROIC
- -0.52%
Growth & Income
- Revenue
- $946.40M · 2.82%
- Net Income
- $-15,774,000 · 83.36%
- EPS
- $-0.06 · 84.07%
- Op Income
- $-4,421,000
- FCF YoY
- 32.37%
Performance & Tape
- 52W High
- $2.89
- 52W Low
- $1.15
- 50D MA
- $1.43
- 200D MA
- $1.82
- Beta
- 0.88
- Avg Volume
- 2.01M
Get TickerSpark's AI analysis on SNDL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SNDL Coverage
We haven't published any research on SNDL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SNDL Report →Similar Companies
ESPR+0.00%
Esperion Therapeutics, Inc.
$3.13
EBS+1.05%
Emergent BioSolutions Inc.
$8.14
SIGA+2.75%
SIGA Technologies, Inc.
$4.49
AQST+1.96%
Aquestive Therapeutics, Inc.
$4.17
CRVS+6.00%
Corvus Pharmaceuticals, Inc.
$12.19
ORGO+4.94%
Organogenesis Holdings Inc.
$2.55
AKBA+12.84%
Akebia Therapeutics, Inc.
$1.01
EOLS+2.49%
Evolus, Inc.
$6.59